1. Design, synthesis and biological evaluation of marine naphthoquinone-naphthol derivatives as potential anticancer agents.
- Author
-
Li Y, Yelv L, Wu X, Liu N, and Zhu Y
- Subjects
- Humans, Structure-Activity Relationship, Molecular Structure, Naphthols pharmacology, Naphthols chemistry, Naphthols chemical synthesis, Cell Line, Tumor, Antineoplastic Agents pharmacology, Antineoplastic Agents chemical synthesis, Antineoplastic Agents chemistry, Naphthoquinones pharmacology, Naphthoquinones chemistry, Naphthoquinones chemical synthesis, Drug Screening Assays, Antitumor, Cell Proliferation drug effects, Apoptosis drug effects, Drug Design, Dose-Response Relationship, Drug
- Abstract
1'-Hydroxy-4',8,8'-trimethoxy-[2,2'-binaphthalene]-1,4-dione (compound 5 ), a secondary metabolite recently discovered in marine fungi, demonstrates promising cytotoxic and anticancer potential. However, knowledge regarding the anticancer activities and biological mechanisms of its derivatives remains limited. Herein, a series of novel naphthoquinone-naphthol derivatives were designed, synthesised, and evaluated for their anticancer activity against cancer cells of different origins. Among these, Compound 13 , featuring an oxopropyl group at the ortho -position of quinone group, exhibited the most potent inhibitory effects on HCT116, PC9, and A549 cells, with IC
50 values decreasing from 5.27 to 1.18 μM (4.5-fold increase), 6.98 to 0.57 μM (12-fold increase), and 5.88 to 2.25 μM (2.6-fold increase), respectively, compared to compound 5 . Further mechanistic studies revealed that compound 13 significantly induced cell apoptosis by increasing the expression levels of cleaved caspase-3 and reducing Bcl-2 proteins through downregulating the EGFR/PI3K/Akt signalling pathway, leading to the inhibition of proliferation in HCT116 and PC9 cells. The present findings suggest this novel naphthoquinone-naphthol derivative may hold potential as an anticancer therapeutic lead.- Published
- 2024
- Full Text
- View/download PDF